Short Interest in Arch Therapeutics, Inc. (OTCMKTS:ARTH) Declines By 55.7%

Arch Therapeutics, Inc. (OTCMKTS:ARTH) was the recipient of a significant drop in short interest in April. As of April 15th, there was short interest totalling 6,600 shares, a drop of 55.7% from the March 31st total of 14,900 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average trading volume of 11,700 shares, the days-to-cover ratio is currently 0.6 days.

Arch Therapeutics Stock Performance

Arch Therapeutics has a fifty-two week low of $0.16 and a fifty-two week high of $1.57. The stock has a fifty day moving average price of $0.20 and a 200-day moving average price of $0.23.

About Arch Therapeutics

Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.